All In Biotech

Free tool

FAERS Monitor: Esbriet

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 208780 or its brand name (Esbriet, Pirfenidone). Reports on generic versions are filed under their own applications.

Reports

40,844

Serious

22,668

55% of reports

Hospitalization

7,942

Death reported

9,477

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • death7,558
  • nausea5,186
  • fatigue3,826
  • diarrhoea3,309
  • decreased appetite3,307
  • dyspnoea3,004
  • weight decreased2,261
  • dizziness2,207
  • cough2,093
  • rash2,048
  • vomiting1,819
  • pneumonia1,794
  • abdominal discomfort1,690
  • headache1,530
  • abdominal pain upper1,513

Reports by year received

View as table
YearReports
20094
201015
20116
201213
201310
2014123
20152,883
20164,177
20172,430
20184,311
20194,319
20205,096
20214,958
20224,745
20233,566
20241,930
20251,287
2026971

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,013,315 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
decreased appetiteSignal3,3077.47.218,315
abdominal discomfortSignal1,6905.25.05,766
deathSignal7,5584.54.521,624
weight decreasedSignal2,2614.24.05,531
coughSignal2,0933.93.74,468
abdominal pain upperSignal1,5133.83.63,133
nauseaSignal5,1863.43.39,018
pneumoniaSignal1,7942.92.72,196
dyspnoeaSignal3,0042.72.63,396
diarrhoeaSignal3,3092.62.63,482
fatigueSignal3,8262.52.53,684
rashSignal2,0482.42.31,744
dizzinessSignal2,2072.32.21,624
vomiting1,8192.01.9920
headache1,5301.31.283

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.